Join
Live feed
·
INSIDERFilingvia Quantisnow
Neurocrine Biosciences Inc. logo

Chief Financial Officer Abernethy Matt converted options into 6,940 shares, covered exercise/tax liability with 9,124 shares and was granted 9,968 shares, increasing direct ownership by 21% to 44,881 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NBIX (Neurocrine Biosciences Inc.) and more on Quantisnow.